中國幸福投資(08116.HK)前三季度虧損收窄80.14%至5425.6萬港元
格隆匯11月14日丨中國幸福投資(08116.HK)發佈三季度業績,截至2019年9月30日止九個月,公司持續經營業務實現收入3156.9萬港元,同比下降81.95%;毛利720.5萬港元,同比下降80.79%;公司擁有人應占虧損5425.6萬港元,同比收窄80.14%;基本每股虧損1.79港仙;不派息。
公告表示,2019年,貿易衝突繼續對商品市場構成壓力。盛柏集團的業績受到貿易衝突所產生的經濟困境所影響。此外,自2019年6月以來,香港發生的持續性社會事件影響了盛柏集團的銷售業績,導致遊客流量大幅下降以及消費者情緒非常低迷,盛柏集團的收益較於2018年同期顯著下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.